Amgen Reports First Quarter 2017 Financial Results
THOUSAND OAKS, Calif., April 26, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2017. Key results include: Total revenues decreased 1 percent versus the first quarter of 2016 to $5.5 billion. GAAP earnings per share (EPS) increased 12 percent to $2.79 driven by higher operating margins. GAAP operating income increased 8 percent to $2.6 billion and GAAP operating margin increased 4 percentage points to 49.8 percent. Non-GAAP EPS increased 9 percent to $3.15 driven by higher operating margins. Non-GAAP operating income increased 5 percent to $...
Source: Amgen News Release - April 26, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Amgen Announces Expanded Commercial Collaboration With Novartis For Erenumab In Migraine
Collaboration Designed to Maximize the Launch of First-in-Class Program and to More Effectively Reach People Living With Migraine THOUSAND OAKS, Calif., April 24, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced an expanded commercial collaboration with Novartis for erenumab, which is being investigated for the prevention of migraine. This expanded commercial collaboration builds on a global neuroscience collaboration in Alzheimer's disease and migraine established in 2015 between Novartis and Amgen. This expanded collaboration leverages Novartis' strong and established presence in neuroscience to more effect...
Source: Amgen News Release - April 24, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Amgen Announces Webcast Of 2017 First Quarter Financial Results
THOUSAND OAKS, Calif., April 21, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter financial results on Wednesday, April 26, 2017, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 2 p.m. PT. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team. Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and...
Source: Amgen News Release - April 21, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news